Skip to main content

Bill · 112th Congress · Senate action May 24, 2012 – Jun 26, 2012

S. 3187

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

Motion Agreed to (92-4) 92–4 on Vote #168 (Jun 26, 2012)

Senate Roll Call Votes on S. 3187 9 recorded

Click any vote to see how every senator voted, with the party breakdown and who crossed party lines.

This page lists recorded Senate roll-call votes only. Voice votes, unanimous-consent actions, and House votes are not shown. Source: Official U.S. Senate roll call vote data (senate.gov).